09:16 AM EDT, 08/20/2024 (MT Newswires) -- IGC Pharma ( IGC ) said Tuesday that its artificial intelligence modeling found molecule IGC-1A to be a potential glucagon-like peptide-1, or GLP-1, agonist.

With this discovery, IGC Pharma ( IGC ) said it is positioned to potentially expand its drug portfolio to metabolic disorders and weight loss.

GLP-1 agonists are known to manage blood sugar levels and promote weight loss, IGC said.